Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating
📰 Original Source
Read full article at Finance →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.